267 related articles for article (PubMed ID: 34119535)
1. Different effects of anti-VEGF drugs (Ranibizumab, Aflibercept, Conbercept) on autophagy and its effect on neovascularization in RF/6A cells.
Wang Y; Yao Y; Li R; Wu B; Lu H; Cheng J; Liu Z; Du J
Microvasc Res; 2021 Nov; 138():104207. PubMed ID: 34119535
[TBL] [Abstract][Full Text] [Related]
2. Role of Autophagy in Hypoxia-Induced Angiogenesis of RF/6A Cells in vitro.
Li R; Du J; Chang Y
Curr Eye Res; 2016 Dec; 41(12):1566-1570. PubMed ID: 27259688
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology study of a chimeric decoy receptor trap fusion protein on retina neovascularization by dual blockage of VEGF and FGF-2.
Jiang J; Xu K; Wang L; Xin W; Zhao G; Huang M; Li S; Luan X; Fang J
Eur J Pharm Sci; 2018 Aug; 121():251-259. PubMed ID: 29715501
[TBL] [Abstract][Full Text] [Related]
4. Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy.
De Cillà S; Farruggio S; Vujosevic S; Raina G; Filippini D; Gatti V; Clemente N; Mary D; Vezzola D; Casini G; Rossetti L; Grossini E
Cell Physiol Biochem; 2017; 42(5):1725-1738. PubMed ID: 28743128
[TBL] [Abstract][Full Text] [Related]
5. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
Deissler HL; Lang GK; Lang GE
Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
[TBL] [Abstract][Full Text] [Related]
6. Response to anti-VEGF-A treatment of endothelial cells in vitro.
Puddu A; Sanguineti R; Traverso CE; Viviani GL; Nicolò M
Exp Eye Res; 2016 May; 146():128-136. PubMed ID: 26771090
[TBL] [Abstract][Full Text] [Related]
7. Autophagy is required for the promoting effect of angiogenic factor with G patch domain and forkhead-associated domain 1 (AGGF1) in retinal angiogenesis.
Li R; Yao G; Zhou L; Zhang M; Yan J; Wang X; Li Y
Microvasc Res; 2021 Nov; 138():104230. PubMed ID: 34339727
[TBL] [Abstract][Full Text] [Related]
8. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro.
Li F; Bai Y; Zhao M; Huang L; Li S; Li X; Chen Y
Ophthalmic Res; 2015; 53(3):109-16. PubMed ID: 25676100
[TBL] [Abstract][Full Text] [Related]
9. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.
Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A
Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435
[TBL] [Abstract][Full Text] [Related]
10. SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR BEFORE AND AFTER INTRAVITREAL INJECTION OF RANIBIZUMAB OR CONBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Jin E; Bai Y; Luo L; Huang L; Zhu X; Ding X; Qi H; Zhao M
Retina; 2017 May; 37(5):971-977. PubMed ID: 27617537
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor regulates primate choroid-retinal endothelial cell proliferation and tube formation through PI3K/Akt and MEK/ERK dependent signaling.
Jin J; Yuan F; Shen MQ; Feng YF; He QL
Mol Cell Biochem; 2013 Sep; 381(1-2):267-72. PubMed ID: 23749166
[TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells.
Kang S; Choi H; Rho CR
J Ocul Pharmacol Ther; 2016 Dec; 32(10):671-676. PubMed ID: 27827554
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept.
Hong HK; Park YJ; Kim DK; Ryoo NK; Ko YJ; Park KH; Kim HM; Woo SJ
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):22. PubMed ID: 33196778
[TBL] [Abstract][Full Text] [Related]
14. Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice.
Hu W; Cai W; Wu Y; Ren C; Yu D; Li T; Shen T; Xu D; Yu J
Int J Nanomedicine; 2024; 19():35-51. PubMed ID: 38187905
[TBL] [Abstract][Full Text] [Related]
15. Decorin inhibits angiogenic potential of choroid-retinal endothelial cells by downregulating hypoxia-induced Met, Rac1, HIF-1α and VEGF expression in cocultured retinal pigment epithelial cells.
Du S; Wang S; Wu Q; Hu J; Li T
Exp Eye Res; 2013 Nov; 116():151-60. PubMed ID: 24016866
[TBL] [Abstract][Full Text] [Related]
16. PERMEABILITY AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR EFFECTS OF BEVACIZUMAB, RANIBIZUMAB, AND AFLIBERCEPT IN POLARIZED RETINAL PIGMENT EPITHELIAL LAYER IN VITRO.
Yoshihara N; Terasaki H; Shirasawa M; Kawano H; Sonoda S; Yamaguchi M; Hashiguchi T; Hisatomi T; Ishibashi T; Sakamoto T
Retina; 2017 Jan; 37(1):179-190. PubMed ID: 28005721
[TBL] [Abstract][Full Text] [Related]
17. IGFBP‑rP1‑silencing promotes hypoxia‑induced angiogenic potential of choroidal endothelial cells via the RAF/MEK/ERK signaling pathway.
Zhu S; Wang H; Zhang Z; Ma M; Zheng Z; Xu X; Sun T
Mol Med Rep; 2020 Dec; 22(6):4837-4847. PubMed ID: 33173998
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.
Yan Z; Shi H; Zhu R; Li L; Qin B; Kang L; Chen H; Guan H
Mol Vis; 2018; 24():83-93. PubMed ID: 29422766
[TBL] [Abstract][Full Text] [Related]
19. Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
Nguyen TT; Guymer R
Expert Rev Clin Pharmacol; 2015; 8(5):541-8. PubMed ID: 26289225
[TBL] [Abstract][Full Text] [Related]
20. A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.
Toledano S; Lu H; Palacio A; Ziv K; Kessler O; Schaal S; Neufeld G; Barak Y
PLoS One; 2016; 11(12):e0168122. PubMed ID: 28036336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
